久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

GSK probe shows tightened drug sector supervision

Xinhua | Updated: 2013-07-19 10:29

BEIJING - An ongoing probe into suspected economic violations by multinational drugmaker GlaxoSmithKline (GSK) employees is being seen as part of efforts to tighten supervision in the medical sector.

The Ministry of Public Security announced last week that some employees from GSK China are being investigated for suspected bribery and tax-related violations. Four senior executives from the company are being held by police over their alleged involvement.

The probe has shed light on instances of hidden bribery that have driven up medicine prices. However, the case is not the first of its kind to be uncovered in China.

In December last year, the US Securities and Exchange Commission (SEC) charged Eli Lilly and Company for its involvement in instances of alleged bribery that occurred in several countries, including China.

Four months before the Eli Lilly case, Pfizer's subsidiary in China was also found to have been involved in bribery.

The GSK suspects are believed to have several methods of concealment, such as channelling bribes through travel agencies.

It is believed that the exposure of the bribery represents just the tip of the iceberg.

An anonymous medical salesman from North China's Tianjin municipality said salesmen have had to come up with more creative ways to bribe doctors and convince them to raise the cost of their medicine.

"In most cases, the doctors don't extort money in such explicit terms, but it is certain that they will not order products from those who do not give them a 'good return'," he said.

The unfair market advantage that enterprises have gained by using bribery may make it harder for smaller companies to survive and develop. In addition, the costs of bribery are eventually transferred to patients.

According to suspect Liang Hong, a medication that costs only 30 yuan to produce could end up setting patients back 300 yuan due to bribery.

Bribery can also affect patients' health, as bribes may influence doctors' decisions regarding what medication to prescribe.

A commerce official said Wednesday that the GSK probe is part of efforts to improve China's business climate and create equal competition opportunities for domestic and overseas investors.

The official said China firmly opposes any form of commercial bribery, and all companies, Chinese and foreign alike, will be subject to legal sanctions and assume legal responsibility if they break Chinese law.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 日韩美女视频在线观看 | 在线观看一区二区三区四区 | 成年人激情视频 | 国产精品国产精品 | 可以看毛片的网站 | 2019天天操天天干天天透 | 精品久久久久久乐 | 久草在线青青草 | 成人免费一区二区三区视频软件 | 欧美一级特黄特黄做受 | 国产黄色小视频 | 一级特黄aaa大片免费看 | 成人精品一区二区不卡视频 | 三级中文字幕永久在线视频 | 中文字幕在线观看不卡视频 | 欧美一级色视频 | 欧美一级特黄特黄毛片 | 宅男69免费永久网站 | 久久香蕉国产精品一区二区三 | 日本欧美韩国一区二区三区 | 国产精品高清在线观看93 | 国产精品久久久久久久hd | 最新国产午夜精品视频不卡 | 久久永久免费视频 | 国产精品2020观看久久 | 国内外成人免费在线视频 | 精品视频一二三区 | 欧美成人看片一区二区三区 | 久草精品在线 | 亚洲国产成人精品91久久久 | 久久久久一级片 | 国产欧美日韩在线视频 | 萌白酱喷水福利视频在线 | 天天看有黄有色大片 | 手机看片久久青草福利盒子 | 一区二区三区免费视频播放器 | 欧美一级在线观看播放 | 成人免费视频一区二区 | 欧美成人影院 在线播放 | 欧美一二三区视频 | 亚洲资源在线播放 |